Understanding the regulatory framework for accessing medicines not currently on the Australian Register of Therapeutic Goods (ARTG) is essential for patient safety. In 2026, the TGA maintains strict clinical oversight to ensure that patients only access these treatments through monitored, legal pathways.

What is an "Unapproved" Medicine?

In Australia, many emerging natural therapies are classified as unapproved therapeutic goods. This designation does not mean the medicine is prohibited; rather, it indicates the product has not undergone the same formal assessment for safety and efficacy as medicines listed on the ARTG.

Because these treatments are not standard, the TGA requires a registered medical practitioner to assess each case and apply for access on the patient's behalf, ensuring the treatment is clinically appropriate for the specific individual.

The Two Primary Legal Pathways

Registered health practitioners typically use one of two frameworks to facilitate legal access to unapproved medicines:

1. The Special Access Scheme (SAS): This pathway allows a doctor to apply to the TGA for a specific medicine for a single patient. The TGA evaluates the clinical justification to ensure that the proposed treatment is suitable for the patient's condition.

2.The Authorised Prescriber (AP) Scheme: The TGA may grant "Authorised Prescriber" status to doctors who have the necessary expertise to prescribe specific classes of unapproved medicines to a particular group of patients. This bypasses the need for individual TGA notifications for every patient, often streamlining the process.

The Importance of Clinical Oversight

While information regarding various prescriptions may be visible online, the TGA emphasizes that safety is dependent on a face-to-face or real-time clinical consultation. Following a compliant medical pathway ensures three critical safeguards:

• Quality Standards: All unapproved medicines must still comply with Therapeutic Goods Orders (such as TGO 93), which set strict requirements for purity and the absence of contaminants.
  
  
• Clinical Safety: A medical assessment allows a practitioner to screen for potential contraindications or adverse interactions with your existing medications.

• Regulatory Compliance: Using the SAS or AP pathways ensures that both the patient and the practitioner are operating within the Australian legal framework.